<DOC>
	<DOCNO>NCT00193713</DOCNO>
	<brief_summary>Study long-term efficacy safety bifeprunox treatment schizophrenia .</brief_summary>
	<brief_title>Bifeprunox Treatment Schizophrenia</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<criteria>diagnosis schizophrenia understand nature study able manage outpatient set longterm bifeprunox treatment current primary diagnosis schizophrenia suicide risk diagnosis history substance abuse uncontrolled hypertension</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2007</verification_date>
	<keyword>double-blind study treatment schizophrenia</keyword>
</DOC>